Cargando…

Circulating microRNA Expression in Cushing’s Syndrome

CONTEXT: Cushing’s syndrome (CS) is a rare disease of endogenous hypercortisolism associated with high morbidity and mortality. Diagnosis and classification of CS is still challenging. OBJECTIVE: Circulating microRNAs (miRNAs) are minimally invasive diagnostic markers. Our aim was to characterize th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vetrivel, Sharmilee, Zhang, Ru, Engel, Mareen, Altieri, Barbara, Braun, Leah, Osswald, Andrea, Bidlingmaier, Martin, Fassnacht, Martin, Beuschlein, Felix, Reincke, Martin, Chen, Alon, Sbiera, Silviu, Riester, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937959/ https://www.ncbi.nlm.nih.gov/pubmed/33692756 http://dx.doi.org/10.3389/fendo.2021.620012

Ejemplares similares

Characterization of Adrenal miRNA-Based Dysregulations in Cushing’s Syndrome
por: Vetrivel, Sharmilee, et al.
Publicado: (2022)

Toward a Diagnostic Score in Cushing's Syndrome
por: Braun, Leah T., et al.
Publicado: (2019)

Steroid profiling using liquid chromatography mass spectrometry during adrenal vein sampling in patients with primary bilateral macronodular adrenocortical hyperplasia
por: Zhang, Ru, et al.
Publicado: (2022)

Case Report: Consecutive Adrenal Cushing’s Syndrome and Cushing’s Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations
por: Detomas, Mario, et al.
Publicado: (2021)

Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission
por: Vogel, Frederick, et al.
Publicado: (2020)

Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications
por: Sbiera, Iuliu, et al.
Publicado: (2021)

Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study
por: Vogel, Frederick, et al.
Publicado: (2021)

Chemosensory dysfunction in Cushing’s syndrome
por: Heger, Elena, et al.
Publicado: (2021)

The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the Spotlight
por: Sbiera, Silviu, et al.
Publicado: (2019)

Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study
por: Detomas, Mario, et al.
Publicado: (2022)

Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study
por: Braun, Leah T., et al.
Publicado: (2021)

Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
por: Sbiera, Iuliu, et al.
Publicado: (2021)

The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients
por: Rubinstein, German, et al.
Publicado: (2022)

Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
por: Liang, Raimunde, et al.
Publicado: (2020)

Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome
por: Detomas, Mario, et al.
Publicado: (2022)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited
por: Braun, Leah T, et al.
Publicado: (2022)

Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome
por: Belaya, Zhanna, et al.
Publicado: (2020)

Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning
por: Marquardt, André, et al.
Publicado: (2021)

OR27-1 11-Oxygenated C19 Steroids Are the Predominant Androgens Responsible for Hyperandrogenemia in Cushing's Disease
por: Adaway, Jo, et al.
Publicado: (2022)

Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
por: Landwehr, Laura-Sophie, et al.
Publicado: (2020)

Driver mutations in USP8 wild-type Cushing’s disease
por: Sbiera, Silviu, et al.
Publicado: (2019)

A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome
por: Albani, Adriana, et al.
Publicado: (2019)

FRI135 Differential Expression Of Circulating MicroRNAs In Primary Aldosteronism: Potential Biomarkers For Improved Diagnosis
por: Lamprou, Stelios, et al.
Publicado: (2023)

11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease
por: Nowotny, Hanna F, et al.
Publicado: (2022)

Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells
por: Kroiss, Matthias, et al.
Publicado: (2011)

Cushing Syndrome Associated Myopathy: It Is Time for a Change
por: Reincke, Martin
Publicado: (2021)

Low SGK1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis
por: Ronchi, Cristina L., et al.
Publicado: (2012)

E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess
por: Zhang, Wei, et al.
Publicado: (2023)

Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
por: Oreglia, Maurine, et al.
Publicado: (2020)

Genomics in Cushing’s Disease: The Dawn of a New Era
por: Reincke, Martin, et al.
Publicado: (2021)

Genetics of Cushing’s disease: from the lab to clinical practice
por: Theodoropoulou, Marily, et al.
Publicado: (2022)

Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
por: Gao, Chang, et al.
Publicado: (2023)

Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly
por: Clemmons, David R., et al.
Publicado: (2023)

Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation
por: Hantel, Constanze, et al.
Publicado: (2016)

SUN-381 Somatic PRKACA Mutations In Patients With Transition From Pituitary-dependent To Adrenal-dependent Cushing’S Syndrome
por: Di Dalmazi, Guido, et al.
Publicado: (2019)

Recurrence after pituitary surgery in adult Cushing’s disease: a systematic review on diagnosis and treatment
por: Braun, Leah T., et al.
Publicado: (2020)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
por: Siebert, Claudia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q236scrbji0vs0agi2t0prbpp3